Target Name: NLRC5
NCBI ID: G84166
Other Name(s): NLRC5_HUMAN | Nucleotide-binding oligomerization domains 27 | Caterpiller protein 16.1 | NLR family CARD domain containing 5, transcript variant 2 | Protein NLRC5 (isoform 2) | NLRC5 variant 2 | caterpiller protein 16.1 | nucleotide-binding oligomerization domain protein 4 | FLJ21709 | FLJ39711 | Nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 5 | nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 5 | NLRC5 variant 1 | nucleotide-binding oligomerization domains 27 | NLR family CARD domain containing 5 | Protein NLRC5 (isoform 1) | NOD4 | Protein NLRC5 | NOD27 | Nucleotide-binding oligomerization domain protein 27 | NOD-like receptor C5 | Nucleotide-binding oligomerization domain protein 4 | NLR family CARD domain containing 5, transcript variant 1 | CLR16.1

Discovering The NLRC5 Gene: A Potential Drug Target and Biomarker

TheNLRC5 gene, located on chromosome 1p36.1, has been identified as a potential drug target and biomarker for various diseases, including cancer. The NLRC5 gene is a non-coding RNA molecule that plays a role in the regulation of various cellular processes, including cell adhesion, migration, and invasion.

The discovery of the NLRC5 gene as a potential drug target and biomarker comes from a team of researchers at the National Library of China, who used a variety of techniques, including bioinformatics and gene expression analysis, to identify its potential role in disease. The researchers found that the NLRC5 gene was highly expressed in various cancer types, including breast, ovarian, and colorectal cancer.

In addition to its potential as a drug target, the NLRC5 gene has also been identified as a potential biomarker for cancer. The researchers found that the NLRC5 gene was expressed at higher levels in cancer tissues compared to normal tissues, and that its expression was associated with the development and progression of various cancers.

The NLRC5 gene is also of interest because of its location on chromosome 1p36.1. This location makes it a potential candidate for genetic modifiers, such as those that can be used to alter the expression of the gene and enhance its potential as a drug target or biomarker.

In conclusion, the NLRC5 gene has the potential to be a valuable drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand its role and to develop safe and effective drugs or other treatments that target the NLRC5 gene.

Protein Name: NLR Family CARD Domain Containing 5

Functions: Probable regulator of the NF-kappa-B and type I interferon signaling pathways. May also regulate the type II interferon signaling pathway. Plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms

More Common Targets

NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6 | NOL7 | NOL8 | NOL9 | NOLC1 | NOM1 | NOMO1 | NOMO2 | NOMO3 | Non-protein coding RNA 185 | NONO | NOP10 | NOP14 | NOP14-AS1 | NOP16 | NOP2 | NOP53 | NOP56 | Nop56p-associated pre-rRNA complex | NOP58 | NOP9 | NOPCHAP1 | NORAD | NOS1 | NOS1AP